Back
Arrowhead Pharmaceuticals Vs. Doximity Industry Stock Comparison
Sell
48
ARWR
Arrowhead Pharmaceuticals
Last Price:
21.64
Seasonality Move:
72.88%
Buy
72
DOCS
Doximity
Last Price:
52.83
Seasonality Move:
-1.56%
Sell
48
Arrowhead Pharmaceuticals (ARWR)
is a Sell
Is Arrowhead Pharmaceuticals a Buy, Sell or Hold?
- The current Arrowhead Pharmaceuticals [ARWR] share price is $21.51. The Score for ARWR is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
- ARWR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
72
Doximity (DOCS)
is a Buy
Is Doximity a Buy, Sell or Hold?
- The current Doximity [DOCS] share price is $58.05. The Score for DOCS is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
- DOCS is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ARWR Stock Price Chart
What is Arrowhead Pharmaceuticals's stock price today?
-
The Arrowhead Pharmaceuticals share price today is $21.51
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ARWR is experiencing slight selling pressure.
DOCS Stock Price Chart
ARWR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.37 | Buy |
| Relative Strength Index (14 RSI): | 59.7 | Buy |
| Chaikin Money Flow: | -38964 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (18.9 - 21.24) | Buy |
| Bollinger Bands (100): | (19.83 - 26.47) | Sell |
DOCS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.42 | Buy |
| Relative Strength Index (14 RSI): | 77.36 | Buy |
| Chaikin Money Flow: | -1048040 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (39.03 - 50.05) | Buy |
| Bollinger Bands (100): | (28.79 - 43.83) | Buy |
ARWR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 21.02 | Buy |
| 20-day SMA: | 20.51 | Buy |
| 50-day SMA: | 20.31 | Buy |
| 200-day SMA: | 25.15 | Sell |
| 8-day EMA: | 21.17 | Buy |
| 20-day EMA: | 20.59 | Buy |
| 50-day EMA: | 20.95 | Buy |
| 200-day EMA: | 24.43 | Sell |
DOCS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 48.68 | Buy |
| 20-day SMA: | 44.82 | Buy |
| 50-day SMA: | 42.35 | Buy |
| 200-day SMA: | 31.69 | Buy |
| 8-day EMA: | 51.24 | Buy |
| 20-day EMA: | 46.6 | Buy |
| 50-day EMA: | 42.49 | Buy |
| 200-day EMA: | 34.23 | Buy |
Arrowhead Pharmaceuticals Earnings Growth & ARWR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, a decrease this year of $3.09 per share, and an increase next year of $0.08 per share.
Doximity Earnings Growth & DOCS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.20 per share, and an increase next year of $0.25 per share.
Arrowhead Pharmaceuticals Technical Analysis
| Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Doximity Technical Analysis
| Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||